Journals / Retina-Vitreus / 2005 / Cilt: 13 - Sayı: 3

Comparison of the largest diameter of lesions measured by FA and ICGVA in patients with age related macular degeneration having subfoveal choroidal neovascular membrane

Subfoveal neovasküler membranı bulunan YBMD’lu hastalarda FA ve İSYVA’da ölçülen en geniş lezyon çaplarının karşılaştırılması

Pages
193–196
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There is no difference between the largest diameters of subfoveal choroidal neovascular membranes measured in FA and ICGVA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To compare the largest membrane diameters measured by Florescein Angiography (FA) and Indocyanine Green Videoangiography (ICGVA) in patients with age related macular degeneration (ARMD) having subfoveal choroidal neovascular membrane.
📊
Key Findings & Data:Materials and Methods: 40 eyes of 30 patients with ARMD having subfoveal choroidal neovascular membrane enrolled to study.
💡
Conclusion & Impact:Conclusion: There is no difference between the largest diameters of subfoveal choroidal neovascular membranes measured in FA and ICGVA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Koroidal neovaskülarizasyon · Floresan anjiyografi · Indonsiyanin yeşili

Abstract

Purpose: To compare the largest membrane diameters measured by Florescein Angiography (FA) and Indocyanine Green Videoangiography (ICGVA) in patients with age related macular degeneration (ARMD) having subfoveal choroidal neovascular membrane. Materials and Methods: 40 eyes of 30 patients with ARMD having subfoveal choroidal neovascular membrane enrolled to study. FA and ICGVA were performed to eyes in same session or in within three days. FA and ICGVA measurements were performed with Zeiss FF 450 plus fundus camera and Visupac 2 digital imaging system. Membranes were divided in three groups as classic, occult and mixed; the largest diameter of membrane was measured in early phase of FA. Measurements of lesions determined in ICGVA were obtained in late phase of angiograms. Means of measurements of largest diameters in FA and ICGVA were obtained and compared with nonparametric Wilcoxon signed rank test. Results: In 10 eyes classic, in 23 eyes occult and in 7 eyes mixed lesions were determined in FA. The mean largest diameter of lesions was 4.26 ± 2.18 mm in classic membrane group in FA, the mean largest diameter of those lesions was 4.57±2.29 mm in ICGVA and the difference was statistically insignificant (p=0.074). Mean largest diameter of mixed lesions was 5.25 ± 1,58 mm in FA, mean diameter of those eyes in ICGVA was 4.75 ± 1.03 mm and the difference was statistically insignificant (p= 0.24). The mean largest diameter of occult membranes was 3.84 ± 1.49 mm in FA, the mean largest lesion diameter of those eyes was 3.40 ± 1.39 mm in ICGVA and difference was not statistically significant (p= 0.54). Conclusion: There is no difference between the largest diameters of subfoveal choroidal neovascular membranes measured in FA and ICGVA.

Özet

Amaç: Subfoveal neovasküler membranı bulunan Yaşa Bağlı Maküla Dejenerasyonlu (YBMD) hastalarda, Floressein Anjiografi (FA) ve İndosiyanin Yeşil Videoanjiografi (İSYVA) ile ölçülen en büyük membran çapının karşılaştırılması. Gereç ve Yöntem: Çalışmaya YBMD'na bağlı subfoveal membranı bulunan 30 hastanın 40 gözü alındı. Tüm gözlere aynı seansta veya en geç üç gün ara ile FA ve İSYVA uygulandı. FA ve İSYVA çekimleri ve ölçümler Zeiss FF 450 plus IR fundus kamera ve Visupac 2 dijital görüntüleme sistemi kullanılarak yapıldı. FA'de membranlar klasik, okkült ve mikst olmak üzere üç gruba ayrıldı ve erken fazda membranın en uzun çapı ölçüldü. İSYVA' da saptanan lezyonlarda ölçüm geç fazda yapıldı. FA ve İSYVA' da ölçülen en uzun çap ortalamaları alınarak nonparametrik Wilcoxon testi ile kıyaslandı. Bulgular: FA' de 10 gözde klasik, 23 gözde okkült, 7 gözde mikst lezyon saptandı. FA'de en uzun lezyon çapı ortalaması klasik membran grubunda 4,26 ± 2,18 mm, bu gözlerin İSYVA' de membran çapı ortalaması 4,57±2,29 mm olarak bulundu ve aradaki fark istatistiksel olarak anlamsızdı (p=0,074). FA'de mikst membranların ortalama çapı 5,25 ± 1,58 mm, bu gözlerin İSYVA çap ortalaması 4,75 ± 1,03 mm bulundu. Aradaki fark istatistiksel olarak anlamsızdı (p=0,24). FA'de okkült membranların en uzun lezyon çapı ortalaması 3,84 ± 1,49 mm, aynı gözlerin İSYVA'de en uzun lezyon çapı ortalaması 3,40 ± 1,39 mm olarak bulundu ve aradaki fark istatistiksel olarak anlamsızdı (p=0,54). Sonuç: YBMD bulunan hastalarda subfoveal neovasküler membranların FA'de ve İSYVA'de ölçülen en uzun lezyon çapları arasında fark yoktur.

🔖

Cite This Article

BAYRAKTAR, Z., UTİNE, A., KAPRAN, Z., ALTAN, T., ACAR, N., ÜNVER, Y. B., ÇAKIR, M., PINARCI, Y. E. (2005). Comparison of the largest diameter of lesions measured by FA and ICGVA in patients with age related macular degeneration having subfoveal choroidal neovascular membrane. Retina-Vitreus, Cilt: 13 - Sayı: 3, 193–196. https://ajindex.com/articles/305329

References (13)

  1. Klein R, Klein BEK, Linton KLP: Prevalence of age related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943
  2. Macular Photocoagulation Study Group: Argon laser photocoagulation for neovascular maculopathy: three year results from randomized clinical trials: Arch Ophthalmol 1986; 104:694-701
  3. Macular Photocoagulation Study Group.: Laser photocoagulation of subfoveal neovascular lesions in age related macular degeneration. Results of a randomised clinical trial: Arch Ophthalmol 1991; 109: 1220-1231
  4. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.: Photodynamic therapy of subfoveal choroidal neovascularization in age related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials - TAP report 1: Arch Ophthalmol 1999; 117:1329-1345
  5. Feucht M, Fuisting B, Richard G: Transpupillary thermotherapy for subfoveal choroidal neovascularization. A 9-month follow-up. Ophthalmologe 2004; 101:1105-1110
  6. Eyetech Study Group: Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2003; 110: 979-986
  7. Yanuzzi LA, Hope-Ross M, Slakter JS et al.: Digital indocyanine videoangiography and choroidal neovascularization. Retina 1992; 12: 191-223
  8. Atmaca LS, Batioglu F, Atmaca P: Yaşa bağlı maküla dejeneresansında koroid neovaskülarizasyonunun indosiyanin yeşili videoanjiografisi. Ret-Vit. 1995; 3: 54-59
  9. Macular Photocoagulation Study Group.: Subfoveal neovascular lesions in age related macular degeneration. Guidelines for evaluation and treatment in the Macular Photocoagulation Study: Arch Ophthalmol 1991; 109: 1242-1257
  10. Guyer DR, Yanuzzi LA: Occult choroidal neovascularization. In Yanuzzi LA, Flower RW, Slakter JS.: Indocyanine green angiography Mosby Year Book, Inc. St Louis, 1997, P: 159-78
  11. Ciulla TA, Danis RP, Harris A: Age-related macular degeneration: a review of experimental treatments: Surv Ophthalmol 1998; 43: 134-146
  12. Treatment of Age Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.: Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three year results of an open label extension of 2 randomized clinical trials-TAP report No 5: Arch Ophthalmol 2002; 120: 1307-1314
  13. Verteporfin in Photodynamic Therapy Study Group: Verteporfin therapy of subfoveal choroidal neovascula